Shanghai Sixth People's Hospital is a teaching hospital in Shanghai, China, affiliated with the School of Medicine, Shanghai Jiao Tong University. The hospital was constructed beside Dishui Lake in Nanhui New City, near the Shanghai Free Trade Zone, covering an area of approximately 72,000 square metres.

There are 600 beds in Shanghai Sixth People's Hospital.

During the past decade, Shanghai Sixth People's Hospital conducted 105 clinical trials. In the 10-year time frame, 105 clinical trials started and 12 clinical trials were completed, i.e. on average, 11.4% percent of trials that started reached the finish line to date. In the past 5 years, 63 clinical trials started and 10 clinical trials were completed. i.e. 15.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shanghai Sixth People's Hospital" #1 sponsor was "Shanghai 6th People's Hospital" with 18 trials, followed by "Shanghai Jiao Tong University Affiliated Sixth People's Hospital" with 6 trials sponsored, "Celgene" with 5 trials sponsored, "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 4 trials sponsored and "Shanghai Jiao Tong University School of Medicine" with 4 trials sponsored. Other sponsors include 95 different institutions and companies that sponsored additional 85 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shanghai Sixth People's Hospital" #1 collaborator was "Shanghai 6th People's Hospital" with 7 trials as a collaborator, "RenJi Hospital" with 5 trials as a collaborator, "Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University" with 5 trials as a collaborator, "Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine" with 4 trials as a collaborator and "Changhai Hospital" with 3 trials as a collaborator. Other collaborators include 85 different institutions and companies that were collaborators in the rest 76 trials.

According to Clinical.Site data, the most researched conditions in "Shanghai Sixth People's Hospital" are "Ischemic Stroke" (4 trials), "Traumatic Brain Injury" (4 trials), "Type 2 Diabetes Mellitus" (4 trials), "Breast Cancer" (3 trials) and "Chronic Heart Failure" (3 trials). Many other conditions were trialed in "Shanghai Sixth People's Hospital" in a lesser frequency.

Most popular intervention types in "Shanghai Sixth People's Hospital" are "Drug" (72 trials), "Device" (13 trials), "Procedure" (13 trials), "Other" (12 trials) and "Diagnostic Test" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "Dexamethasone" (3 trials), "rhNRG-1" (3 trials), "Anlotinib" (2 trials) and "Azacitidine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Shanghai Sixth People's Hospital" are 129 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are 58 active trials in "Shanghai Sixth People's Hospital". 5 are not yet recruiting, 42 are recruiting, 10 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 46 completed trials in Shanghai Sixth People's Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Shanghai Sixth People's Hospital, 11 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 36 trials that are defined as “Not Applicable".